-
Micro and Nano 3D investigation of complex gut alterations-dementia interplay
Authors:
F. Palermo,
N. Marrocco,
L. Dacomo,
E. Grisafi,
M. Musella,
V. Moresi,
A. Sanna,
L. Massimi,
I. Bukreeva,
O. Junemann,
I. Viola,
M. Eckermann,
P. Cloetens,
T. Weitkamp,
G. Gigli,
G. Logroscino,
N. Kerlero de Rosbo,
C. Balducci,
A. Cedola
Abstract:
Alzheimer's disease (AD), a debilitating neurodegenerative disorder, remains one of the foremost public health challenges of our time. Despite decades of research, its etiology largely remains enigmatic. Recently, attention has turned to the gut-brain axis, a complex network of communication between the gastrointestinal tract and the brain, as a potential player in the pathogenesis of AD. Here we…
▽ More
Alzheimer's disease (AD), a debilitating neurodegenerative disorder, remains one of the foremost public health challenges of our time. Despite decades of research, its etiology largely remains enigmatic. Recently, attention has turned to the gut-brain axis, a complex network of communication between the gastrointestinal tract and the brain, as a potential player in the pathogenesis of AD. Here we exploited X-ray Phase Contrast Tomography to provide an in-depth analysis of the link between the gut condition and AD, exploring gut anatomy and structure in murine models. We conducted a comprehensive analysis by comparing the outcomes in various mouse models of cognitive impairment, including AD, frail mice, and frontotemporal dementia (FTD) affected mice. We discovered an association between substantial changes in the gut structure and the presence of amyloid-beta (A\b{eta}) in the brain. We found that the most important gut alterations are related to A\b{eta} occurrence in the brain. In particular, we investigated the gut morphology, the distribution of enteric micro-processes and neurons in the ileum. Understanding the intricate interplay between gut condition and dementia may open new avenues for early AD diagnosis and treatment offering hope for a future where these diseases may be more effectively addressed.
△ Less
Submitted 24 April, 2024; v1 submitted 25 January, 2024;
originally announced January 2024.
-
Quantitative characterization of amyloid deposits in murine models of alzheimer disease by phase-contrast x-ray imaging
Authors:
A. Politano,
L. Massimi,
N. Pieroni1,
F. Palermo,
A. Sanna,
M. Fratini,
I. Bukreeva,
C. Balducci,
A. Cedola
Abstract:
Alzheimer's is a neurodegenerative disease that is the most common form of dementia, but there is still no definitive cure for this disease. The noninvasive X-ray Phase Contrast Tomography (XPCT) imaging technique was used to study brain tissues in mouse models of Alzheimer's disease, AP-PS1 and APP23. The XPCT technique enabled high-resolution imaging of brain tissues, distinguishing between diff…
▽ More
Alzheimer's is a neurodegenerative disease that is the most common form of dementia, but there is still no definitive cure for this disease. The noninvasive X-ray Phase Contrast Tomography (XPCT) imaging technique was used to study brain tissues in mouse models of Alzheimer's disease, AP-PS1 and APP23. The XPCT technique enabled high-resolution imaging of brain tissues, distinguishing between different brain structures, such as amyloid deposits and neuronal cells. In addition, the XPCT technique provided detailed information on the distribution and morphology of amyloid deposits in AP-PS1 and APP23 mice putting in evidence the differences between these two models. This work demonstrates the effectiveness of this technique in supporting Alzheimer's studies and evaluating new therapeutic strategies.
△ Less
Submitted 6 June, 2023;
originally announced June 2023.
-
X-ray Phase Contrast Tomography to assess the sequential evolution of multi-organ damage in an animal model of multiple sclerosis
Authors:
F. Palermo,
N. Pieroni,
A. Sanna,
B. Parodi,
C. Venturi,
G. Begani,
L. Massimi,
L. Maugeri,
E. Longo,
L. Damico,
G. Tromba,
I. Bukreeva,
M. Fratini,
G. Gigli,
N. Kerlero-Rosbo,
A. Cedola
Abstract:
We use X-ray phase-contrast tomography (XPCT) in a multi-organ approach to identify early imaging markers predictive of multiple sclerosis (MS) in EAE animal model. As the majority of neurodegenerative diseases, MS is characterized by a progressive accumulation of biological deficits across different organs and systems. A simultaneous imaging of different disease-relevant networks and a multiscale…
▽ More
We use X-ray phase-contrast tomography (XPCT) in a multi-organ approach to identify early imaging markers predictive of multiple sclerosis (MS) in EAE animal model. As the majority of neurodegenerative diseases, MS is characterized by a progressive accumulation of biological deficits across different organs and systems. A simultaneous imaging of different disease-relevant networks and a multiscale imaging, ranging from the single cell through to the organ as a whole, are required to provide complete reliable information. XPCT offers the unprecedented possibility to investigate structural and cellular alterations at brain, gut, and eye levels in a multiscale approach. The comparison between naive mice and EAE-affected mice sacrificed at different time points and the correlation of the data from different organs and different time points, unveils the identification of early changes in organs possible predictive of the disease.
△ Less
Submitted 26 April, 2022;
originally announced April 2022.
-
Immuno-Histo X-ray Phase Contrast Tomography: New 3D imaging technique for molecular tomography
Authors:
A. Quarta,
A. Sanna,
N. Pieroni,
B. Parodi,
F. Palermo,
I. Bukreeva,
M. Fratini,
L. Massimi,
D. Simeone,
X. Le Guével,
A. Bravin,
I. Viola,
E. Quintiero,
G. Gigli,
N. Kerlero de Rosbo,
L. Sancey,
A. Cedola
Abstract:
The still unmet ability of following the fate of specific cells or molecules within the whole body would give an outstanding breakthrough in the comprehension of disease mechanisms and in the monitoring of therapeutic approaches. Our idea is to push forward the bio-nanotechnology to a level where it serves the most advanced 3D bio-medical imaging to provide a multi-scale imaging ranging from the w…
▽ More
The still unmet ability of following the fate of specific cells or molecules within the whole body would give an outstanding breakthrough in the comprehension of disease mechanisms and in the monitoring of therapeutic approaches. Our idea is to push forward the bio-nanotechnology to a level where it serves the most advanced 3D bio-medical imaging to provide a multi-scale imaging ranging from the whole organ down to the cellular level, enabling high-resolution visualization of disease-relevant cells within the whole disease-altered biological context. We present here the first proof-of-concept of a novel tomography procedure, Immuno-Histo-X-ray Phase Contrast Tomography (XPCT) that combines cutting-edge XPCT, which provides detailed image of the whole organ, with molecular imaging at the cellular level, identifying the relevant cells via an immunohistochemistry-based approach. We combine metal nanoparticles and a single-domain antibody that target relevant cells. Our results lay the foundation for a new generation of 3D-bio-medical X-ray imaging.
△ Less
Submitted 6 June, 2023; v1 submitted 11 April, 2022;
originally announced April 2022.
-
Glioblastoma Treatments with Photo-Nanotherapeutics Induce Massive Devascularization and Tumor Elimination
Authors:
Loredana Ricciardi,
Sharmistha Chatterjee,
Giovanna Palermo,
Elisabeta I. Szerb,
Alessia Sanna,
Francesca Palermo,
Nicola Pieroni,
Michela Fratini,
Roberto Bartolino,
Alessia Cedola,
Massimo La Deda,
Giuseppe Strangi
Abstract:
Glioblastoma multiforme (GBM) is one of the deadliest and most aggressive cancers, remarkably resilient to current therapeutic treatments. Here, we report in vivo studies of GBM treatments based on photo-nanotherapeutics able to induce synergistic killing mechanisms. Core-shell nanoparticles have been weaponized by combining the photophysical properties of an Ir(III) complex - a new generation PDT…
▽ More
Glioblastoma multiforme (GBM) is one of the deadliest and most aggressive cancers, remarkably resilient to current therapeutic treatments. Here, we report in vivo studies of GBM treatments based on photo-nanotherapeutics able to induce synergistic killing mechanisms. Core-shell nanoparticles have been weaponized by combining the photophysical properties of an Ir(III) complex - a new generation PDT agent - with the thermo-plasmonic effects of resonant gold nanospheres. To investigate the damages induced in GBM treated with these nanosystems and exposed to optical radiation, we recurred to the X-ray phase contrast tomography (XPCT). This high-resolution 3D imaging technique highlighted a vast devascularization process by micro-vessels disruption, which is responsible of a tumor elimination without relapse.
△ Less
Submitted 13 January, 2021;
originally announced January 2021.
-
Cross-code gyrokinetic verification and benchmark on the linear collisionless dynamics of the geodesic acoustic mode
Authors:
A. Biancalani,
A. Bottino,
C. Ehrlacher,
V. Grandgirard,
G. Merlo,
I. Novikau,
Z. Qiu,
E. Sonnendruecker,
X. Garbet,
T. Goerler,
S. Leerink,
F. Palermo,
D. Zarzoso
Abstract:
The linear properties of the geodesic acoustic modes (GAM) in tokamaks are investigated by means of the comparison of analytical theory and gyrokinetic numerical simulations. The dependence on the value of the safety factor, finite-orbit-width of the ions in relation to the radial mode width, magnetic-flux-surface sha**, and electron/ion mass ratio are considered. Nonuniformities in the plasma p…
▽ More
The linear properties of the geodesic acoustic modes (GAM) in tokamaks are investigated by means of the comparison of analytical theory and gyrokinetic numerical simulations. The dependence on the value of the safety factor, finite-orbit-width of the ions in relation to the radial mode width, magnetic-flux-surface sha**, and electron/ion mass ratio are considered. Nonuniformities in the plasma profiles (such as density, temperature, or safety factor), electro-magnetic effects, collisions and presence of minority species are neglected. Also, only linear simulations are considered, focusing on the local dynamics. We use three different gyrokinetic codes: the lagrangian (particle-in-cell) code ORB5, the eulerian code GENE and semi-lagrangian code GYSELA. One of the main aims of this paper is to provide a detailed comparison of the numerical results and analytical theory, in the regimes where this is possible. This helps understanding better the behavior of the linear GAM dynamics in these different regimes, the behavior of the codes, which is crucial in the view of a future work where more physics is present, and the regimes of validity of each specific analytical dispersion relation.
△ Less
Submitted 18 May, 2017;
originally announced May 2017.
-
Decay of geodesic acoustic modes due to the combined action of phase mixing and Landau dam**
Authors:
A. Biancalani,
F. Palermo,
C. Angioni,
A. Bottino,
F. Zonca
Abstract:
Geodesic acoustic modes (GAMs) are oscillations of the electric field whose importance in tokamak plasmas is due to their role in the regulation of turbulence. The linear collisionless dam** of GAMs is investigated here by means of analytical theory and numerical simulations with the global gyrokinetic particle-in-cell code ORB5. The combined effect of the phase mixing and Landau dam** is foun…
▽ More
Geodesic acoustic modes (GAMs) are oscillations of the electric field whose importance in tokamak plasmas is due to their role in the regulation of turbulence. The linear collisionless dam** of GAMs is investigated here by means of analytical theory and numerical simulations with the global gyrokinetic particle-in-cell code ORB5. The combined effect of the phase mixing and Landau dam** is found to quickly redistribute the GAM energy in phase-space, due to the synergy of the finite orbit width of the passing ions and the cascade in wave number given by the phase mixing. When plasma parameters characteristic of realistic tokamak profiles are considered, the GAM decay time is found to be an order of magnitude lower than the decay due to the Landau dam** alone, and in some cases of the same order of magnitude of the characteristic GAM drive time due to the nonlinear interaction with an ITG mode. In particular, the radial mode structure evolution in time is investigated here and reproduced quantitatively by means of a dedicated initial value code and diagnostics.
△ Less
Submitted 11 August, 2016;
originally announced August 2016.
-
Flow dynamics and magnetic induction in the von-Karman plasma experiment
Authors:
Nicolas Plihon,
Guillaume Bousselin,
Francesco Palermo,
Jorge A. Morales,
Wouter Bos,
Fabien S. Godeferd,
Mickaël Bourgoin,
Jean-François Pinton,
M. Moulin,
Ane Aanesland
Abstract:
The von-Karman plasma experiment is a novel versatile experimental device designed to explore the dynamics of basic magnetic induction processes and the dynamics of flows driven in weakly magnetized plasmas. A high-density plasma column (10^16 - 10^19 particles.m^-3) is created by two radio-frequency plasma sources located at each end of a 1 m long linear device. Flows are driven through JxB azimu…
▽ More
The von-Karman plasma experiment is a novel versatile experimental device designed to explore the dynamics of basic magnetic induction processes and the dynamics of flows driven in weakly magnetized plasmas. A high-density plasma column (10^16 - 10^19 particles.m^-3) is created by two radio-frequency plasma sources located at each end of a 1 m long linear device. Flows are driven through JxB azimuthal torques created from independently controlled emissive cathodes. The device has been designed such that magnetic induction processes and turbulent plasma dynamics can be studied from a variety of time-averaged axisymmetric flows in a cylinder. MHD simulations implementing volume-penalization support the experimental development to design the most efficient flow-driving schemes and understand the flow dynamics. Preliminary experimental results show that a rotating motion of up to nearly 1 km/s is controlled by the JxB azimuthal torque.
△ Less
Submitted 10 September, 2014;
originally announced September 2014.
